Palliative gastrojejunostomy in unresectable cancer and gastric outlet obstruction: a retrospective cohort study.
Aged
Aged, 80 and over
Cohort Studies
Duodenal Neoplasms
/ complications
Eating
Female
Gallbladder Neoplasms
/ complications
Gastric Bypass
/ methods
Gastric Outlet Obstruction
/ etiology
Gastrointestinal Transit
Humans
Laparoscopy
/ methods
Laparotomy
/ methods
Length of Stay
Male
Middle Aged
Neoplasm Staging
Neoplasms
/ complications
Operative Time
Palliative Care
/ methods
Pancreatic Neoplasms
/ complications
Postoperative Complications
/ epidemiology
Retrospective Studies
Stomach Neoplasms
/ complications
Survival Rate
Treatment Outcome
Gastric bypass
Gastric outlet obstruction
Gastroenterostomy
Gastrojejunostomy
Palliative care
Journal
Annals of the Royal College of Surgeons of England
ISSN: 1478-7083
Titre abrégé: Ann R Coll Surg Engl
Pays: England
ID NLM: 7506860
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
entrez:
1
3
2021
pubmed:
2
3
2021
medline:
16
3
2021
Statut:
ppublish
Résumé
Palliative gastrojejunostomy is a surgical technique that allows restoration of oral intake among patients with gastric outlet obstruction (GOO) caused by unresectable neoplasms. Research suggests standard treatment for malignant GOO should be laparoscopic gastrojejunostomy (LGJ). This study presents the clinical outcomes of palliative gastrojejunostomy and compares results from LGJ and open gastrojejunostomy (OGJ) at our centre. We performed a retrospective analysis on patients who underwent palliative gastrojejunostomy for GOO caused by unresectable neoplasms between 2008 and 2018. We included demographic variables, time to recover intestinal transit, time to recover oral intake, hospital stay, complications and global survival. A total of 39 patients underwent palliative gastrojejunostomy (20 OGJ, 19 LGJ). Patients in the LGJ group recovered oral intake and intestinal transit faster than those in the OGJ group (3 vs 5 days, Palliative LGJ allows earlier restoration of oral intake and does not increase morbidity or mortality. Palliative LGJ should be considered the standard treatment for these patients.
Identifiants
pubmed: 33645283
doi: 10.1308/rcsann.2020.7016
pmc: PMC9158038
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
197-202Références
Surg Laparosc Endosc. 1998 Apr;8(2):92-6
pubmed: 9566559
Gastrointest Endosc. 2013 Jul;78(1):55-62
pubmed: 23522025
Langenbecks Arch Surg. 2016 Sep;401(6):777-85
pubmed: 27339200
Surg Endosc. 2006 Dec;20(12):1831-4
pubmed: 17063298
Gastrointest Endosc. 2010 Mar;71(3):490-9
pubmed: 20003966
J Gastrointest Surg. 2009 Jul;13(7):1238-44
pubmed: 19399561
Surg Endosc. 2010 Feb;24(2):290-7
pubmed: 19551436
JSLS. 2011 Apr-Jun;15(2):169-73
pubmed: 21902969
Am Surg. 2018 Jun 1;84(6):991-995
pubmed: 29981637
Gastrointest Endosc. 2015 Sep;82(3):460-8.e2
pubmed: 25851162
Arch Surg. 1997 Feb;132(2):184-7
pubmed: 9041924
J Hepatobiliary Pancreat Surg. 2005;12(6):474-8
pubmed: 16365822
BMC Gastroenterol. 2007 Jun 08;7:18
pubmed: 17559659
Radiographics. 2004 Nov-Dec;24(6):1561-73
pubmed: 15537965
Pancreatology. 2018 Jul;18(5):601-607
pubmed: 29753623
Br J Surg. 2004 Feb;91(2):205-9
pubmed: 14760669
Cochrane Database Syst Rev. 2018 May 30;5:CD012506
pubmed: 29845610
Gastrointest Endosc. 2015 Feb;81(2):321-32
pubmed: 25085332
World J Gastroenterol. 2018 May 14;24(18):1978-1988
pubmed: 29760541
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1295-1302.e1
pubmed: 30391433
J Gastrointest Surg. 2017 Aug;21(8):1220-1225
pubmed: 28224464
J Clin Gastroenterol. 2017 Nov/Dec;51(10):896-899
pubmed: 28697151
Am J Surg. 2013 Aug;206(2):210-7
pubmed: 23735668
Surg Endosc. 2002 Nov;16(11):1620-6
pubmed: 12073005